US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist
  • 1.450
  • +0.030+2.11%
Close Dec 13 16:00 ET
  • 1.490
  • +0.040+2.76%
Post 19:53 ET
76.48MMarket Cap-0.49P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ALX Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

ALX Oncology Earnings Reports

  • ALX Oncology | 8-K: ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 7 16:11 ET

  • ALX Oncology | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:09 ET

  • ALX Oncology | 10-Q: Q2 2024 Earnings Report

    Aug 12 16:08 ET

  • ALX Oncology | 8-K: ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 8 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 14, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data